Known targets — ChEMBL curated mechanism
AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA
The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL28672424 | 0.97 | SLC34A1 (0.30) | SLC34A1 | |
| SCHEMBL4823616 | 0.94 | — | — | |
| Lithium Ion SCHEMBL21749348 | 0.94 | — | — | |
| SCHEMBL553542 | 0.94 | — | — | |
| SCHEMBL920065 | 0.94 | — | — | |
| SCHEMBL7860312 | 0.94 | — | — | |
| Silver SCHEMBL555009 | 0.94 | — | — | |
| Tetramethylammonium Ion SCHEMBL1758243 | 0.88 | — | — | |
| Potassium Ion SCHEMBL18394942 | 0.81 | SLC34A1 (0.32) | SLC34A1 | |
| Potassium Ion SCHEMBL29609917 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 466 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116836374-B | Liquid crystal polymer, LCP fiber and preparation method and application thereof | 珠海万通特种工程塑料有限公司 | 2025-03-18 | — | — | CN | claimed |
| WO-2024179608-A1 | LIQUID CRYSTAL POLYMER, LCP FIBERS, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 珠海万通特种工程塑料有限公司 | 2024-09-06 | — | — | WO | claimed |
| CN-118290471-A | Synthesis method of di-tert-butyl phosphate potassium salt | 诚达药业股份有限公司 | 2024-07-05 | — | — | CN | claimed |
| WO-2024128570-A1 | METHOD FOR PRODUCING CRYSTALLINE FIBER USING CARBOXYLIC ACID, SULFONIC ACID, PHOSPHORIC ACID, OR ACID SALT DERIVATIVE THEREOF | (주)비에이에너지 | 2024-06-20 | — | — | WO | claimed |
| CN-113816992-B | Preparation method of di-tert-butyl phosphate potassium salt | 大连双硼医药化工有限公司 | 2024-05-07 | — | — | CN | claimed |
| EP-4323491-A1 | CLEANING COMPOSITION | Entegris, Inc. (US) | 2024-02-21 | — | — | EP | claimed |
| CN-117295811-A | cleaning composition | 恩特格里斯公司 | 2023-12-26 | — | — | CN | claimed |
| CN-116836374-A | Liquid crystal polymer, LCP fiber and preparation method and application thereof | 珠海万通特种工程塑料有限公司 | 2023-10-03 | — | — | CN | claimed |
| US-20220336210-A1 | CLEANING COMPOSITION | MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT | 2022-10-20 | — | — | US | claimed |
| WO-2022221497-A1 | CLEANING COMPOSITION | ENTEGRIS, INC. (US) | 2022-10-20 | — | — | WO | claimed |
| CN-113816992-A | Preparation method of potassium di-tert-butyl phosphate | 大连双硼医药化工有限公司 | 2021-12-21 | — | — | CN | claimed |
| US-11008311-B2 | Potassium salt of benzimidazole compound and preparation method therefor, composition and application thereof | WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD. (CN) | 2021-05-18 | — | — | US | claimed |
| EP-3447054-B1 | COMPOUND AND PREPARATION METHOD THEREFOR, COMPOSITION AND APPLICATION THEREOF | WUHAN LL SCIENCE & TECHNOLOGY DEVELOPMENT CO LTD (CN) | 2021-01-20 | — | — | EP | claimed |
| CN-112110909-A | Compound, preparation method, composition and application thereof | 武汉朗来科技发展有限公司 | 2020-12-22 | — | — | CN | claimed |
| CN-107400122-B | Compound, preparation method, composition and application thereof | 武汉朗来科技发展有限公司 | 2020-10-23 | — | — | CN | claimed |
| US-20140364464-A1 | CRYSTALLINE FORMS OF AZILSARTAN MEDOXOMIL POTASSIUM AND PREPARATION AND USES THEREOF | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2014-12-11 | — | — | US | claimed |
| WO-2013104342-A1 | CRYSTALLINE FORMS OF AZILSARTAN MEDOXOMIL POTASSIUM AND PREPARATION AND USES THEREOF | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2013-07-18 | — | — | WO | claimed |
| EP-0900227-B1 | IMPROVED PROCESS FOR THE SYNTHESIS OF DIESTERS OF PHOSPHORIC ACID 2,5-DIOXO-4,4-DIPHENYL-IMIDAZOLIDIN-1-YLMETHYL ESTER | WARNER LAMBERT CO (US) | 2001-12-12 | — | — | EP | claimed |
| CN-116234794-B | Low reactivity hydrocarbon dispersants in aqueous polymerization of fluoropolymers | THE CHEMOURS COMPANY FC, LLC (US) | 2026-05-26 | — | — | CN | disclosed |
| WO-1997041132-A1 | IMPROVED PROCESS FOR THE SYNTHESIS OF DIESTERS OF PHOSPHORIC ACID 2,5-DIOXO-4,4-DIPHENYL-IMIDAZOLIDIN-1-YLMETHYL ESTER | WARNER-LAMBERT COMPANY (US) | 1997-11-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11008311-B2 | Potassium salt of benzimidazole compound and preparation method therefor, composition and application thereof | REN, AGTR1, AGTR2 | SLC34A1 338/4885 |
| US-20140364464-A1 | CRYSTALLINE FORMS OF AZILSARTAN MEDOXOMIL POTASSIUM AND PREPARATION AND USES THEREOF | KCNN2, KCNN1, REN | SLC34A1 433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.